Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380
暂无分享,去创建一个
D Wyper | E K Perry | R H Perry | E. Perry | S. Pimlott | D. Wyper | E. Jaros | R. Perry | M. Piggott | J. Court | E. Greally | J A Court | E Jaros | S L Pimlott | M Piggott | J Owens | E Greally | J. Owens | Evelyn Jaros | Robert H. Perry | Elaine K. Perry
[1] J. Changeux,et al. Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.
[2] Walter G. Sannita,et al. Cholinergic modulation, visual function and Alzheimer's dementia , 1997, Vision Research.
[3] E. Perry,et al. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[4] R. B. Cross,et al. Demonstration of neurofibrillary tangles in paraffin sections: a quick and simple method using a modification of Palmgren's method. , 1982, Medical laboratory sciences.
[5] H. Schröder,et al. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. , 2000, Brain research. Molecular brain research.
[6] E. Perry,et al. Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease , 1993, Alzheimer disease and associated disorders.
[7] J. Seibyl,et al. Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates. , 2001, Nuclear medicine and biology.
[8] Michele Zoli,et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain , 1995, Nature.
[9] John O'Brien,et al. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease , 2003, Journal of Chemical Neuroanatomy.
[10] T. Taniguchi,et al. Changes in Nicotinic and Muscarinic Cholinergic Receptors in Alzheimer‐Type Dementia , 1986, Journal of neurochemistry.
[11] Robert B. Innis,et al. 5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors , 2000 .
[12] K. Kellar,et al. [3H]cytisine binding to nicotinic cholinergic receptors in brain. , 1991, Molecular pharmacology.
[13] Agneta Nordberg,et al. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (±)-[3 H]epibatidine , 1998, Brain Research.
[14] J K Lynch,et al. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. , 1997, Journal of medicinal chemistry.
[15] J. Changeux,et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits , 1999, Nature.
[16] E. Perry,et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication , 2000, Neuroscience.
[17] R. Dannals,et al. 5-[I-125/123]lodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. , 1998, Life sciences.
[18] J. Rinne,et al. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease , 1991, Brain Research.
[19] A. Nordberg,et al. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography , 1998, Neuroscience.
[20] Autoradiographic Distribution of Nicotinic Receptor Sites Labelled with [3H]Cytisine in the Human Brain , 1995 .
[21] C D Marsden,et al. Altered Muscarinic and Nicotinic Receptor Densities in Cortical and Subcortical Brain Regions in Parkinson's Disease , 1993, Journal of neurochemistry.
[22] M. Quik,et al. 5‐Iodo‐A‐85380 binds to α‐conotoxin MII‐sensitive nicotinic acetylcholine receptors (nAChRs) as well as α4β2* subtypes , 2002 .
[23] E. Perry,et al. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types , 2000, Acta neurologica Scandinavica. Supplementum.
[24] E. Perry,et al. The role of the cholinergic system in the development of the human cerebellum. , 1995, Brain research. Developmental brain research.
[25] Agneta Nordberg,et al. Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.
[26] E. Perry,et al. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease , 1990, Journal of the Neurological Sciences.
[27] H. Eisenberg,et al. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein , 1999, The European journal of neuroscience.
[28] S. Rogers,et al. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. , 1992, Molecular pharmacology.
[29] E. Perry,et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use , 1998, Neuroscience.
[30] A. C. Collins,et al. 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. , 2000, Molecular pharmacology.
[31] E. Perry,et al. Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum , 2002, Neuroscience.
[32] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[33] A. C. Collins,et al. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum , 2001, Journal of neurochemistry.
[34] D. Irving,et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology , 1995, Neuroscience.
[35] A. Nordberg,et al. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. , 1995, Neuroreport.
[36] E. Perry,et al. α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's Disease , 1999 .
[37] M. Mesulam,et al. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.
[38] E. Perry,et al. Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I]α-bungarotoxin binding , 1997, Journal of Chemical Neuroanatomy.
[39] E. London,et al. Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. , 1999, Nuclear medicine and biology.
[40] E. Perry,et al. Alpha4 but not alpha3 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease , 1999 .
[41] S. Gauthier,et al. Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases , 1992, Journal of neurochemistry.
[42] S. Dunnett,et al. Targeting the subthalamic nucleus in the treatment of Parkinson’s disease , 1998, Brain Research Bulletin.
[43] D. Price,et al. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease , 1988, Neurology.
[44] A. Nordberg,et al. Decreased Protein Levels of Nicotinic Receptor Subunits in the Hippocampus and Temporal Cortex of Patients with Alzheimer’s Disease , 2000, Journal of neurochemistry.
[45] C Martin-Ruiz,et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. , 2002, Brain : a journal of neurology.
[46] Robert H. Perry,et al. Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.
[47] Mrc Psych,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .
[48] J. Changeux,et al. Distribution and Pharmacology of α6-Containing Nicotinic Acetylcholine Receptors Analyzed with Mutant Mice , 2002, The Journal of Neuroscience.
[49] A. Nordberg,et al. Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains , 1995 .
[50] Margaret A. Johnson,et al. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. , 1997, Brain research. Developmental brain research.
[51] E. Perry,et al. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex , 2002, Consciousness and Cognition.
[52] I G McKeith,et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.
[53] Carmen Martin-Ruiz,et al. Nicotinic receptors in human brain: topography and pathology , 2000, Journal of Chemical Neuroanatomy.
[54] Carmen Martin-Ruiz,et al. Nicotinic receptor abnormalities in Alzheimer’s disease , 2001, Biological Psychiatry.
[55] C. Geula,et al. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. , 1996, Cerebral cortex.
[56] Jerry J Buccafusco,et al. Neuronal nicotinic receptor subtypes: defining therapeutic targets. , 2004, Molecular interventions.
[57] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[58] S. Wonnacott,et al. Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.